BofA raised the firm’s price target on Arrowhead (ARWR) to $93 from $81 and keeps a Buy rating on the shares. The firm’s raised target reflects a refined view of the Redemplo-sHTG total addressable market, as it now models $3B in peak sales versus $2.4B previously forecast, the analyst tells investors.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ARWR:
- Arrowhead presents long-term efficacy, safety data for plozasiran
- Maintaining Buy on Arrowhead: APOC3-Driven Value Unlocked by Shasta-3/4 Amid Obesity Program Uncertainty
- Wave data brings questions about Arrowhead ‘back to center stage,’ says Leerink
- Arrowhead price target lowered to $81 from $84 at BofA
- Arrowhead Shareholders Reject Say-on-Pay at 2026 Meeting